Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2024 07:00 ET | Source: FibroGen, Inc.

FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024

SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM...
May 08, 2023 16:01 ET | Source: FibroGen, Inc.

FibroGen Reports First Quarter 2023 Financial Results

• Topline Data From Four Phase 3 Trials Expected Through 3Q 2023 • Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value • Entered Into...
April 24, 2023 07:00 ET | Source: FibroGen, Inc.

FibroGen to Report First Quarter 2023 Financial Results

SAN FRANCISCO, April 24, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its first quarter 2023 financial results on Monday, May 8 after the market close. FibroGen will also...
July 23, 2020 11:00 ET | Source: ROHM Semiconductor

LAPIS Semiconductor’s Speech Synthesis ICs Equipped with Playback Anomaly Detection Function

Yokohama, Japan and Santa Clara, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- ROHM Group company LAPIS Semiconductor recently announced the automotive speech synthesis ICs, ML2253x series, optimized...
November 12, 2019 11:00 ET | Source: ROHM Semiconductor

LAPIS Semiconductor's New Multiband Wireless Communication LSI Optimized for Smart Meters World-wide

Yokohama, Japan and Santa Clara, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- ROHM Group company LAPIS Semiconductor recently announced the availability of a multiband (sub-1GHz/2.4GHz) wireless...
October 23, 2019 07:00 ET | Source: FibroGen, Inc

FibroGen Announces First Patient Dosed in LAPIS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients With Locally Advanced Pancreatic Cancer

SAN FRANCISCO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced the dosing of the first patient in the LAPIS Phase 3 clinical study of pamrevlumab in patients with...
March 12, 2019 15:19 ET | Source: ROHM Semiconductor

LAPIS Semiconductor's 16-bit General-Purpose MCUs Equipped with Safety Functions

Yokohama and Santa Clara, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- ROHM Group company LAPIS Semiconductor recently announced the availability of the ML62Q1300/1500/1700 Group of general-purpose...
September 05, 2017 11:35 ET | Source: ROHM Semiconductor

The Industry’s First Dual-Mode LPWA (Low Power Wide Area) Compliant Wireless Communication LSI

Yokohama, Japan and Santa Clara, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yokohama and Santa Clara, Calif., – September 5, 2017 – ROHM Group company LAPIS Semiconductor has recently announced the...
June 27, 2017 18:10 ET | Source: ROHM Semiconductor

LAPIS Semiconductor’s Breakthrough Soil Environment Sensor

Yokohama, Japan and Santa Clara, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- ROHM Group company LAPIS Semiconductor has recently announced the development of a soil environment sensor ideal for...